WuXi AppTec Co., Ltd. (WUXIF)

Market Cap	20.83B
Revenue (ttm)	5.49B
Net Income (ttm)	1.15B
Shares Out	n/a
EPS (ttm)	0.39
PE Ratio	n/a
Forward PE	n/a
Dividend	0.14 (3.68%)
Ex-Dividend Date	Jun 17, 2024

Volume	39
Open	6.160
Previous Close	n/a
Day's Range	3.780 - 6.160
52-Week Range	3.740 - 12.690
Beta	0.83
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally. The company operates in six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2000
• Employees: 41,116
• Stock Exchange: OTCMKTS
• Ticker Symbol: WUXIF

Financial Performance

In 2023, WuXi AppTec's revenue was 40.34 billion, an increase of 2.51% compared to the previous year's 39.35 billion. Earnings were 9.61 billion, an increase of 9.00%.

Financial numbers in CNY